Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C₄₄Mab-34, for Multiple Applications against Oral Carcinomas

Cluster of differentiation 44 (CD44) has been investigated as a cancer stem cell (CSC) marker as it plays critical roles in tumor malignant progression. The splicing variants are overexpressed in many carcinomas, especially squamous cell carcinomas, and play critical roles in the promotion of tumor...

Descripción completa

Detalles Bibliográficos

Autores principales:	Hiroyuki Suzuki, Kazuki Ozawa, Tomohiro Tanaka, Mika K. Kaneko, Yukinari Kato
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2023-04-01
Colección:	Biomedicines
Materias:	CD44 CD44 variant 7/8 monoclonal antibody flow cytometry immunohistochemistry
Acceso en línea:	https://www.mdpi.com/2227-9059/11/4/1099
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!